Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape

Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape

Summary

This reports provides a data-driven overview of the current and future competitive landscape in Smoking Cessation therapeutics.

Synopsis

• In 2022, Nearly 350 million people will quit smoking across the 16 countries covered in GlobalData’s epidemiology forecast for smoking cessation.
• There are two leading marketed drugs for the treatment of smoking cessation.
• R&D activity in smoking cessation is sparse, with less than 10 innovator products in mid-to-late stage pipeline development.
• Non-commercial sponsors dominate clinical trial development in smoking cessation, with the US emerging as the key countries for conducting trials in smoking cessation.
• Deals involving strategic alliances of smoking cessation assets are the most common type of deals globally.
• Within the next 18 months, no regulatory filing or commercial launch in smoking cessation is expected.

Scope

GlobalData’s Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include -

Disease Landscape
Disease Overview
Epidemiology Overview
Treatment Overview
Marketed Products Assessment
Breakdown by Mechanism of Action, Molecule Type and Route of Administration
Product Profiles with Sales Forecast
Pipeline Assessment
Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
Late-to-mid-stage Pipeline Drugs
Phase Transition Success Rate and Likelihood of Approval
Clinical Trials Assessment
Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
Enrolment Analytics, Site Analytics, Feasibility Analysis
Deals Landscape
Mergers, Acquisitions, and Strategic Alliances by Region
Overview of Recent Deals
Commercial Assessment
Key Market Players
Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the Smoking Cessation market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Smoking Cessation market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.